— Know what they know.
Not Investment Advice

BBIO NASDAQ

BridgeBio Pharma, Inc.
1W: +2.7% 1M: +4.1% 3M: -17.0% YTD: -11.3% 1Y: +27.9% 3Y: +182.3% 5Y: +47.1%
$69.37
+1.22 (+1.79%)
 
Weekly Expected Move ±3.8%
$63 $66 $69 $71 $74
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 58 · $13.6B mcap · 167M float · 1.80% daily turnover · Short 59% of daily vol
Credit Risk of going bust: lower than 52% of companies Debt: 15.5% of company value Bonds: $309.3M held by 77 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.42 (down 98%), BridgeBio Pharma, Inc. would be worth roughly what it owes.
Total debt $2.49B against a stock market value of $13.56B.
Distance to default 5.37 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.51B (short-term plus half of long-term), stock volatility 46.4%; Altman Z'' -14.10. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Oct Typical
☀️
Sunny
+49.7% YTD avg
Midterm Year
⛈️
Stormy
-36.6% YTD avg
2026 Now
⛈️
Stormy
Below typical
20yr Avg YTD
+49.7%
Day 206 of 252
Midterm Year YTD
-36.6%
Presidential cycle avg
2026 YTD
-11.3%
Below 20yr avg
Typical Vol
54%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
-0.0%
Midterm
⛈️
-37.0%
43% win 66% vol
Feb
20yr
💨
+1.0%
Midterm
⛈️
-51.9%
43% win 70% vol
Mar
20yr
💨
+8.6%
Midterm
⛈️
-40.9%
43% win 122% vol
Apr
20yr
⛈️
-1.4%
Midterm
⛈️
-50.9%
29% win 65% vol
May
20yr
⛈️
+5.7%
Midterm
⛈️
-61.6%
29% win 70% vol
Jun
20yr
💨
+26.5%
Midterm
⛈️
-42.2%
75% win 68% vol
Jul
20yr
💨
+50.6%
Midterm
⛈️
-47.5%
62% win 112% vol
Aug
20yr
💨
+48.5%
Midterm
⛈️
-38.8%
62% win 63% vol
Sep
20yr
⛈️
+41.6%
Midterm
⛈️
-42.1%
25% win 59% vol
Oct
20yr
💨
+50.1%
Midterm
⛈️
-39.2%
75% win 54% vol
Now: +5.4%
Nov
20yr
💨
+64.7%
Midterm
⛈️
-45.4%
71% win 72% vol
Dec
20yr
💨
+4.7%
Midterm
⛈️
-18.7%
71% win 122% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: -11.3%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms